CME Group Inc. (NASDAQ:CME) Shares Bought by State of Michigan Retirement System

State of Michigan Retirement System lifted its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 0.1% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 98,644 shares of the financial services provider’s stock after buying an additional 100 shares during the period. State of Michigan Retirement System’s holdings in CME Group were worth $21,237,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in CME. Mutual Advisors LLC purchased a new stake in CME Group during the third quarter worth about $206,000. Truist Financial Corp increased its stake in CME Group by 15.9% in the 3rd quarter. Truist Financial Corp now owns 82,384 shares of the financial services provider’s stock valued at $16,495,000 after purchasing an additional 11,307 shares in the last quarter. Shelton Capital Management raised its holdings in CME Group by 522.2% during the third quarter. Shelton Capital Management now owns 14,179 shares of the financial services provider’s stock worth $2,839,000 after purchasing an additional 11,900 shares during the last quarter. Ameriprise Financial Inc. boosted its position in CME Group by 3.6% during the third quarter. Ameriprise Financial Inc. now owns 3,579,057 shares of the financial services provider’s stock worth $716,604,000 after purchasing an additional 125,263 shares in the last quarter. Finally, Evergreen Capital Management LLC grew its holdings in CME Group by 1.8% in the third quarter. Evergreen Capital Management LLC now owns 9,728 shares of the financial services provider’s stock valued at $1,948,000 after purchasing an additional 173 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other CME Group news, Director Elizabeth A. Cook sold 1,000 shares of the business’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $211.52, for a total transaction of $211,520.00. Following the sale, the director now directly owns 18,241 shares in the company, valued at approximately $3,858,336.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Charles P. Carey sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the transaction, the director now owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The disclosure for this sale can be found here. Over the last three months, insiders sold 54,290 shares of company stock worth $11,393,700. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on CME shares. Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $222.00 to $226.00 and gave the stock a “market perform” rating in a research report on Thursday, April 25th. Barclays increased their target price on CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a report on Thursday, April 25th. Bank of America boosted their price target on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Argus lifted their price objective on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Finally, JPMorgan Chase & Co. lowered shares of CME Group from a “neutral” rating to an “underweight” rating and reduced their target price for the company from $206.00 to $187.00 in a report on Friday, June 21st. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $215.90.

Check Out Our Latest Stock Report on CME Group

CME Group Stock Performance

Shares of CME stock opened at $197.08 on Wednesday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. The company’s fifty day moving average price is $204.90 and its two-hundred day moving average price is $208.48. The firm has a market capitalization of $70.96 billion, a P/E ratio of 22.42, a P/E/G ratio of 5.18 and a beta of 0.52. CME Group Inc. has a 12 month low of $180.11 and a 12 month high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.44 by $0.06. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The company’s revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.42 earnings per share. On average, research analysts anticipate that CME Group Inc. will post 9.75 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were paid a $1.15 dividend. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.33%. CME Group’s dividend payout ratio (DPR) is 52.33%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.